First Time Loading...
J

JCR Pharmaceuticals Co Ltd
TSE:4552

Watchlist Manager
JCR Pharmaceuticals Co Ltd
TSE:4552
Watchlist
Price: 628 JPY -1.88% Market Closed
Updated: May 16, 2024

Net Margin
JCR Pharmaceuticals Co Ltd

13%
Current
20%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13%
=
Net Income
5.4B
/
Revenue
41.4B

Net Margin Across Competitors

Country JP
Market Cap 78.4B JPY
Net Margin
13%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 744.4B USD
Net Margin
17%
Country DK
Market Cap 4.1T DKK
Net Margin
37%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country US
Market Cap 367.4B USD
Net Margin
45%
Country US
Market Cap 333.6B USD
Net Margin
4%
Country UK
Market Cap 188.7B GBP
Net Margin
13%
Country CH
Market Cap 182.5B CHF
Net Margin
30%
Country CH
Market Cap 181.4B CHF
Net Margin
20%
Country US
Market Cap 162.7B USD
Net Margin
-1%

Profitability Report

View the profitability report to see the full profitability analysis for JCR Pharmaceuticals Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13%
=
Net Income
5.4B
/
Revenue
41.4B
What is the Net Margin of JCR Pharmaceuticals Co Ltd?

Based on JCR Pharmaceuticals Co Ltd's most recent financial statements, the company has Net Margin of 13%.